Skip to main content

Table 3 Comparison of clinical demographics between IBD patients according HBsAg positivity

From: Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region

 

HBsAg positive

(n = 23)

HBsAg negative

(n = 383)

P value

Age (Mean ± SD)a

44.1 ± 9.5

44.9 ± 13.9

0.783

Sex (Male) (n; %)b

12 (52.2)

228 (59.5)

0.775

Crohn’s vs ulcerative colitis (ratio)b

1.09

0.823

0.512

Previous surgery (n; %)b

5 (21.7)

53 (13.8)

0.298

Disease Flare (n; %)b

8 (8.7)

59 (10.6)

0.770

Admission (n; %)b

7 (30.4)

69 (18)

0.145

5ASA (n; %)b

8 (34.8)

186 (48.5)

0.199

Thiopurine (n; %)b

13 (56.5)

148 (38.6)

0.093

Steroid (n; %)b

6 (26.1)

54 (14.1)

0.116

Biologics (n; %)b

2 (8.7)

7 (1.8)

0.030

  1. 5ASA 5-aminosalicylic acid
  2. aunpaired t-test
  3. bChi Square test